FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to a compound, its diastereomers and pharmaceutically acceptable salts. Invention also relates to a pharmaceutical composition and to a method of treating a HIV-infected mammal.
EFFECT: technical result is obtaining novel compounds which are useful as HIV maturation inhibitors.
7 cl, 4 tbl, 75 ex
Title | Year | Author | Number |
---|---|---|---|
TRITERPENE DERIVATIVES OF LUPEOL TYPE AS ANTIVIRAL PREPARATIONS | 2010 |
|
RU2561604C2 |
PROPENOATE BETULIN DERIVATIVES | 2012 |
|
RU2613554C2 |
METHOD OF PRODUCING BETULIN 28-HEMISUCCINATE | 2010 |
|
RU2435779C1 |
MACROHETEROCYCLIC NUCLEOSIDE DERIVATIVES AND ANALOGUES THEREOF, PRODUCTION AND USE | 2017 |
|
RU2731385C1 |
CLASS OF BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUNDS FOR TARGETED DESTRUCTION OF ANDROGEN RECEPTORS AND USE THEREOF | 2020 |
|
RU2825000C2 |
TLR7/8 ANTAGONISTS AND THEIR APPLICATION | 2017 |
|
RU2758686C2 |
CONDENSED QUINOLINE DERIVATIVE AND USE THEREOF | 2005 |
|
RU2384571C2 |
SHIP1 MODULATORS AND METHODS RELATED THERETO | 2014 |
|
RU2679805C2 |
RMT5 INHIBITORS | 2019 |
|
RU2814198C2 |
BENZIMIDAZOLE DERIVATIVES | 2020 |
|
RU2803284C1 |
Authors
Dates
2020-03-12—Published
2017-02-02—Filed